Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE
Clinical trial NCT02686346 · COMPLETED
Trial details
- NCT number
- NCT02686346
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-10-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.